Los Angeles, CA and Vancouver, BC, May 28, 2025 - BioSig Technologies, Inc. (Nasdaq: BSGM) and Streamex Exchange Corporation have successfully completed their previously disclosed share exchange transaction. The merger forms a company specializing in the tokenization of real-world assets, particularly focusing on commodities. Streamex will become a wholly owned subsidiary of BioSig, with Streamex Co-Founder and CEO Henry McPhie taking the helm as CEO of the combined company. Morgan Lekstrom, Co-Founder and Chairman of Streamex, will serve as Chairman of the Board. Anthony Amato, the current CEO of BioSig, will transition to a role on the Board of Directors. The move is aimed at accelerating growth and scaling technology in the tokenization and commodities industries.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.